Telix Pharmaceuticals Ltd banner

Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 14.72 AUD -0.88% Market Closed
Market Cap: AU$5B

Intrinsic Value

The intrinsic value for Telix Pharmaceuticals Ltd (TLX) under the Base Case is 11.97 AUD. Compared with the current market price of 14.72 AUD, the stock appears Overvalued by 19% .

Based on two methods:

DCF suggests overvaluation, while multiples suggest undervaluation.

TLX Intrinsic Value
11.97 AUD
Overvaluation 19%
Intrinsic Value
Price AU$14.72
Bear Case
Base Case
Bull Case
Monitor TLX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value AU$9.58
Get notified when the price drops into your buy zone
Current Price AU$14.72
Intrinsic Value AU$11.97
Margin of Safety 20% AU$9.58
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about TLX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TLX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Telix Pharmaceuticals Ltd.

Explain Valuation
Alternatives to TLX

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Telix Pharmaceuticals Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one TLX stock?

The intrinsic value for Telix Pharmaceuticals Ltd (TLX) under the Base Case is 11.97 AUD.

Is TLX stock undervalued or overvalued?

Compared with the current market price of 14.72 AUD, the stock appears Overvalued by 19% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett